Why the study?
Does primary aldosteronism increase the prevalence of type 2 diabetes mellitus and metabolic syndrome compared to a matched background population?
Population
305 newly diagnosed primary aldosteronism patients from the prospective German Conn's Registry and 2,454…
Comparison
Primary aldosteronism (disease exposure) vs Matched control cohort from the background…
Design
Cohort
Authors
Loading...
May elevate cardiometabolic risk in PA; leaves open causal mechanisms and intervention effects.
Does primary aldosteronism increase the prevalence of type 2 diabetes mellitus and metabolic syndrome compared to a matched background population?
Patients with primary aldosteronism have a significantly higher prevalence of type 2 diabetes and metabolic syndrome compared to matched controls, which may contribute to their increased cardiovascular morbidity and mortality.
Hanslik et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: